Durvalumab Intravenous and Medroxyprogesterone

• Generic Name: durvalumab
• Dosage Forms: n.a.
• Other Brand Names: Imfinzi

Durvalumab injection is used to treat urothelial carcinoma (a type of bladder cancer) that has spread throughout the body (metastatic) or cannot be removed by surgery (advanced). Durvalumab is given to patients who have received other cancer medicines (eg, platinum) but did not work well.

Durvalumab injection is also used to treat non-small cell lung cancer (NSCLC) that has not spread and cannot be removed by surgery. It is given to patients who have received other cancer medicines (eg, platinum) and radiation treatment for their NSCLC.

Durvalumab is to be given only by or under the supervision of your doctor.

• Generic Name: medroxyprogesterone
• Dosage Forms: n.a.
• Other Brand Names: Provera, Depo-Provera, Depo-subQ provera 104, Depo-Provera Contraceptive

Medroxyprogesterone is a progestin (a form of progesterone), a female hormone that helps regulate ovulation (the release of an egg from an ovary) and menstrual periods.

Medroxyprogesterone is used to treat conditions such as absent or irregular menstrual periods, or abnormal uterine bleeding. Medroxyprogesterone is also used to decrease the risk of endometrial hyperplasia (a condition that may lead to uterine cancer) while taking estrogens.

Medroxyprogesterone is also used to prevent overgrowth in the lining of the uterus in postmenopausal women who are receiving estrogen hormone replacement therapy.